Over the course of the year they’ve completely developed a SARS Covid vaccine, completed numerous pre clinical studies, completed three or four stringent manufacturing runs, communicated numerous times with the fda and are on the cusp of IND approval to begin human studies all without any BARDA or government funding. And without any significant funding activity of their own other than small grabs which cause much pain while struggling on the otcbb. The press release said the buildout on Arizona began which the CEO would like to discuss. In all fairness, I believe you wanted a CC the week after the last because you couldn’t ask questions. Joe noted that problem in his press release so there should be enough to discuss plus anything else positive along the way.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links